GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 28.86B |
| Revenue (ttm) | 19.67B |
| Net Income (ttm) | 1.99B |
| Shares Out | 457.84M |
| EPS (ttm) | 4.34 |
| PE Ratio | 14.53 |
| Forward PE | 13.46 |
| Dividend | $0.14 (0.22%) |
| Ex-Dividend Date | Apr 25, 2025 |
| Volume | 2,730,553 |
| Open | 64.50 |
| Previous Close | 64.39 |
| Day's Range | 62.66 - 64.80 |
| 52-Week Range | 57.65 - 94.80 |
| Beta | 1.31 |
| Analysts | Buy |
| Price Target | 97.73 (+55.05%) |
| Earnings Date | Apr 29, 2025 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther... [Read more]
Financial Performance
In 2024, GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $97.73, which is an increase of 55.05% from the latest price.
News
Cincinnati Children's and GE HealthCare build collaborative research program to drive pediatric imaging innovation
CHICAGO--(BUSINESS WIRE)--Cincinnati Children's and GE HealthCare (Nasdaq: GEHC) will form a strategic research program focused on driving clinical and technical research to advance innovation for ped...
GE HealthCare: Looking Healthier Here
GE HealthCare, spun off from GE in early 2023, has seen its stock trade between $60-$90, now trading at the low end of the range. The company reports nearly $20 billion in sales and is gradually posti...
GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effe...
GE HealthCare and FPT Expand Strategic Partnership to Drive AI-Powered Healthcare Innovation
HANOI, Vietnam--(BUSINESS WIRE)-- #FPT--Global IT firm FPT and GE HealthCare announced a Strategic Cooperation Agreement, expanding their commercial alliance to advance product strategy and developmen...
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP), f...
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
CHICAGO--(BUSINESS WIRE)--At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe,i a new computed tomography (CT) system with Unlimite...
GE HealthCare announces cash dividend for first quarter of 2025
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 paya...
ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Sess...
US population is aging: here are the top 2 stocks set to benefit
The US population is aging. In fact, according to Mizuho analysts, those aged 75 and more will likely make up about 10% of the country's population by the end of this decade.
GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (...
GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions
SAN JOSE, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pione...
NVIDIA and GE HealthCare Collaborate to Advance the Development of Autonomous Diagnostic Imaging With Physical AI
New NVIDIA Isaac for Healthcare Medical Device Simulation Platform to Fast-Track Development of Autonomous Imaging Systems and Robotics New NVIDIA Isaac for Healthcare Medical Device Simulation Platfo...
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the u...
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.
GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Portfolio to Improve Speed of Digital Innovation Adoption
LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will b...
GE HealthCare names new president and CEO, China
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effecti...
GE HealthCare unveils Freelium, a next-generation sealed magnet platform at ECR 2025 to support equitable and sustainable access to MR
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled Freelium™,ii a next-generation sealed magnet platform, that aims to enable high-quality Magnetic Resonance (MR) imaging with less ...
Patients in the US undergo first doses of GE HealthCare's new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--Patients undergo first doses of GE HealthCare's PET radiotracer Flyrcado (flurpiridaz F 18) injection at early adopter sites in the US.
Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
FORT COLLINS, Colo., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX:ENL) a leader in healthcare imaging data solutions, and its subsidiary Laitek, announces a collaboration with GE HealthCare, ...
Why Is GE HealthCare Stock Trading Soaring On Thursday?
On Thursday, GE HealthCare GEHC reported fourth-quarter adjusted EPS of $1.45, up from $1.18 a year ago, beating the consensus of $1.26.
GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO...
GE HealthCare forecasts upbeat 2025 profit on steady medical device demand
GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.
GE HealthCare Posts Q4 Profit Above Expectations
GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates.
GE Healthcare's business grows with boost from imaging and diagnostic drug units
Medical-technology company's revenue falls slightly short of estimate, but adjusted profit beats target.
GE HealthCare Stock Rises on Strong Earnings and Outlook
The medical imaging company issues solid guidance for 2025.